Confront the urgent unmet challenge of hard-to-control hypertension and its dire implications for cardiovascular and kidney health. Despite existing treatments, high mortality and complications persist. This presentation reveals cutting-edge insights into the pathogenic effects of aldosterone excess as an unaddressed driver of hypertension, contributing to heart failure, cardiovascular disease, and chronic kidney disease. Be part of the conversation to ignite a transformative dialogue on redefining hypertension management.
PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.
Learning Objectives:
Understand the Historical and Current Perspectives on Hypertension Management: Learn about the evolution of hypertension management and significant paradigm shifts influenced by clinical data and guidelines.
Identify Unmet Needs and Challenges in Hypertension Control: Explore the existing challenges in managing hypertension, the prevalence of uncontrolled hypertension and factors contributing to inadequate blood pressure management, including aldosterone dysregulation.
Recognize the Role of Aldosterone in Hypertension and Associated Risks: Investigate the pathophysiological role of aldosterone in hypertension, its association with increased cardiovascular and kidney disease risk.
